Literature DB >> 33024330

COVID-19 vaccines: how to ensure Africa has access.

John N Nkengasong, Nicaise Ndembi, Akhona Tshangela, Tajudeen Raji.   

Abstract

Entities:  

Keywords:  Developing world; Government; SARS-CoV-2; Vaccines

Mesh：

Substances：

Year:  2020        PMID： 33024330     DOI： 10.1038/d41586-020-02774-8

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Let Africa into the market for COVID-19 diagnostics.

Authors:  John Nkengasong
Journal:  Nature       Date:  2020-04       Impact factor: 49.962

2.  Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1.

Authors:  David P Fidler
Journal:  PLoS Med       Date:  2010-05-04       Impact factor: 11.069

3.  Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention.

Authors:  Sarah M Bartsch; Kelly J O'Shea; Marie C Ferguson; Maria Elena Bottazzi; Patrick T Wedlock; Ulrich Strych; James A McKinnell; Sheryl S Siegmund; Sarah N Cox; Peter J Hotez; Bruce Y Lee
Journal:  Am J Prev Med       Date:  2020-07-15       Impact factor: 5.043
  3 in total
  30 in total

Review 1.  Recent Update of COVID-19 Vaccines.

Authors:  Sameer A Jadaan; Abdul Waheed Khan
Journal:  Adv Pharm Bull       Date:  2021-10-04

2.  A Mapping Review on the Uptake of the COVID-19 Vaccine among Adults in Africa Using the 5A's Vaccine Taxonomy.

Authors:  Michael E Kalu; Oluwagbemiga Oyinlola; Michael C Ibekaku; Israel I Adandom; Anthony O Iwuagwu; Chigozie Ezulike; Ernest C Nwachukwu; Ekezie Uduonu
Journal:  Am J Trop Med Hyg       Date:  2022-05-09       Impact factor: 3.707

Review 3.  Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.

Authors:  Lakshmi Manoharan; Piero Olliaro; Peter W Horby; Conall H Watson
Journal:  Trials       Date:  2021-05-29       Impact factor: 2.279

4.  Tracer Pharmaceuticals Availability and Distribution Trends Prior to and During the Covid-19 Pandemic: A Comparative Study.

Authors:  Tafesse Gizaw; Awol Jemal; Tadesse Gudeta
Journal:  J Multidiscip Healthc       Date:  2022-01-11

5.  Household Energy Insecurity and COVID-19 Have Independent and Synergistic Health Effects on Vulnerable Populations.

Authors:  Godfred O Boateng; Laura M Phipps; Laura E Smith; Frederick A Armah
Journal:  Front Public Health       Date:  2021-01-21

Review 6.  The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation.

Authors:  Piotr Rzymski; Leszek Borkowski; Marcin Drąg; Robert Flisiak; Jacek Jemielity; Jacek Krajewski; Agnieszka Mastalerz-Migas; Andrzej Matyja; Krzysztof Pyrć; Krzysztof Simon; Michał Sutkowski; Jacek Wysocki; Joanna Zajkowska; Andrzej Fal
Journal:  Vaccines (Basel)       Date:  2021-02-01

7.  Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials.

Authors:  Toby Pepperrell; Florence Rodgers; Pranav Tandon; Kelly Sarsfield; Molly Pugh-Jones; Theo Rashid; Sarai Keestra
Journal:  Glob Health Action       Date:  2021-01-01       Impact factor: 2.640

8.  Knowledge, Attitudes, and Practices Regarding COVID-19 among Healthcare Workers in Uganda: A Cross-Sectional Survey.

Authors:  Onesmus Kamacooko; Jonathan Kitonsa; Ubaldo M Bahemuka; Freddie M Kibengo; Anne Wajja; Vincent Basajja; Alfred Lumala; Ayoub Kakande; Paddy Kafeero; Edward Ssemwanga; Robert Asaba; Joseph Mugisha; Benjamin F Pierce; Robin J Shattock; Pontiano Kaleebu; Eugene Ruzagira
Journal:  Int J Environ Res Public Health       Date:  2021-06-30       Impact factor: 3.390

9.  Marketing the COVID-19 vaccine and the implications for public health.

Authors:  Emmanuel Mogaji
Journal:  Vaccine       Date:  2021-07-13       Impact factor: 4.169

10.  COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.

Authors:  Marguerite Massinga Loembé; John N Nkengasong
Journal:  Immunity       Date:  2021-07-13       Impact factor: 31.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.